AKAM vs PDSB · P/E 27, rev $2.17B vs $50.7M cap
Akamai Technologies Inc (AKAM) versus PDS Biotechnology Corp (PDSB) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
PDS Biotechnology Corp (PDSB) is a biotechnology company listed on NASDAQ.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
PDSB does not have a complete income-statement cache yet.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. PDSB currently screens at market cap $50.7M.
Not investment advice. Open the AKAM and PDSB stock pages for the full models.
Not investment advice.